SavedAdd your journal

Journals / Ulusal Travma ve Acil Cerrahi Dergisi / 2022 / Cilt: 28 - Sayı: 2

Features of patients with upper gastrointestinal bleeding and factors affecting the re-bleeding risk

Emin UYSAL
Yahya Ayhan ACAR
Pages
147–154
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was a significant difference between patients with and without endoscopic intervention for re-bleeding (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:BACKGROUND: The risk of re-bleeding in upper gastrointestinal bleeding (UGIB) is a major complication that can be mortal.
📊
Key Findings & Data:Ac cording to these findings, Glasgow-Blatchford and AIMS65 scores of the patients were calculated.
💡
Conclusion & Impact:There was a significant difference between patients with and without endoscopic intervention for re-bleeding (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

BACKGROUND: The risk of re-bleeding in upper gastrointestinal bleeding (UGIB) is a major complication that can be mortal. In this study, we aimed to determine the factors that can predict the risk of re-bleeding in UGIB patients. METHODS: We retrospectively screened UGIB patients admitted in adult intensive care. Along with age and gender, complaints of admission, vital signs, comorbidities, laboratory findings, medications, endoscopy status, and re-bleeding status were recorded. Ac cording to these findings, Glasgow-Blatchford and AIMS65 scores of the patients were calculated. All statistical tests were performed with the Predictive Analytics Software (PASW®, version 18, SPSS Inc., Chicago, IL). RESULTS: A total of 241 patients were included in the study. Mean age of patients was 57.58±19.31, years and 176 (73.0%) of them were male. A total of 117 (48.5%) patients were Helicobacter pylori positive and re-bleeding occurred in 77 (32.0%) patients. Sclero therapy was applied in 103 (42.7%) patients, while 5 (2.1%) underwent electrocoagulation, and 4 (1.7%) underwent hemoclips. There was a significant difference between patients with and without endoscopic intervention for re-bleeding (p

🔖

Cite This Article

UYSAL, E., ACAR, Y. A. (2022). Features of patients with upper gastrointestinal bleeding and factors affecting the re-bleeding risk. Ulusal Travma ve Acil Cerrahi Dergisi, Cilt: 28 - Sayı: 2, 147–154. https://ajindex.com/articles/644035

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Tielleman T, Bujanda D, Cryer B. Epidemiology and risk factors for upper gastrointestinal bleeding. Gastrointest Endosc Clin N Am 2015;25:415– 28
  2. Hreinsson JP, Kalaitzakis E, Gudmundsson S, Björnsson ES. Upper gastrointestinal bleeding: Incidence, etiology and outcomes in a popula tion-based setting. Scand J Gastroenterol 2013;48:439–47
  3. Jafar W, Jafar AJ, Sharma A. Upper gastrointestinal haemorrhage: An up date. Frontline Gastroenterol 2016;7:32–40
  4. Robertson M, Majumdar A, Boyapati R, Chung W, Worland T, Terbah R, et al. Risk stratification in acute upper GI bleeding: Comparison of the AIMS65 score with the Glasgow-Blatchford and Rockall scoring sys tems. Gastrointest Endosc 2016;83:1151–60
  5. Stanley AJ, Laine L, Dalton HR, Ngu JH, Shultz M, Abazi R, et al. Com parison of risk scoring systems for patients presenting with upper gas trointestinal bleeding: International multi-centre prospective study. BMJ 2017;356:i6432
  6. Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet 2000;356:1318–21
  7. Saltzman JR, Tabak YP, Hyett BH, Sun X, Travis AC, Johannes RS. A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding. Gastrointest Endosc 2011;74:1215– 24
  8. Nam JH, Jeon TJ, Cho JH, Kim J. Risk factors of the rebleeding accord ing to the patterns of nonvariceal upper gastrointestinal bleeding. Turk J Gastroenterol 2017;28:266–71
  9. Moledina SM, Komba E. Risk factors for mortality among patients ad mitted with upper gastrointestinal bleeding at a tertiary hospital: A pro spective cohort study. BMC Gastroenterol 2017;17:165
  10. Kim JJ, Sheibani S, Park S, Buxbaum J, Laine L. Causes of bleeding and outcomes in patients hospitalized with upper gastrointestinal bleeding. J Clin Gastroenterol 2014;48:113–8
  11. Han YJ, Cha JM, Park JH, Jeon JW, Shin HP, Joo KR. Successful en doscopic hemostasis is a protective factor for rebleeding and mortality in patients with nonvariceal upper gastrointestinal bleeding. Dig Dis Sci 2016;61:2011–8
  12. Turedi S, Gunduz A, Yandi M. An etiological and prognostic evaluation of patients with upper gastrointestinal bleeding from Karadeniz Techni cal University Department of Emergency Medicine. Turk J Emerg Med 2010;10:20–5
  13. Bardou M, Quenot JP, Barkun A. Stress-related mucosal disease in the critically ill patient. Nat Rev Gastroenterol Hepatol 2015;12:98–107
  14. Cheon JH, Kim JS,